Fresenius Medical Care Corporation
$ 22.37
0.40%
11 Jun - close price
- Market Cap 12,004,839,000 USD
- Current Price $ 22.37
- High / Low $ 22.59 / 22.24
- Stock P/E 11.89
- Book Value 28.26
- EPS 1.88
- Next Earning Report 2026-08-04
- Dividend Per Share $1.49
- Dividend Yield 3.9 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 27.84
- 52 Week Low 19.24
About
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Analyst Target Price
$26.54
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-25 | 2024-11-05 | 2024-07-30 | 2024-05-07 | 2024-02-20 | 2023-11-01 | 2023-08-02 |
| Reported EPS | 0.455 | 0.72 | 0.55 | 0.46 | 0.42 | 0.455 | 0.41 | 0.35 | 0.32 | 0.44 | 0.28 | 0.3 |
| Estimated EPS | 0.5265 | 0.55 | 0.5 | 0.47 | 0.38 | 0.4005 | 0.35 | 0.34 | 0.25 | 0.3 | 0.31 | 0.28 |
| Surprise | -0.0715 | 0.17 | 0.05 | -0.01 | 0.04 | 0.0545 | 0.06 | 0.01 | 0.07 | 0.14 | -0.03 | 0.02 |
| Surprise Percentage | -13.5802% | 30.9091% | 10% | -2.1277% | 10.5263% | 13.608% | 17.1429% | 2.9412% | 28% | 46.6667% | -9.6774% | 7.1429% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.49 |
| Currency | EUR |
Previous Dividend Records
| Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | May 2022 | Jan 1970 | Sep 2020 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-08 | 2025-06-06 | 2024-06-03 | 2023-06-01 | 2022-05-27 | None | 2020-09-11 | None | None | None |
| Amount | $0.871575 | $0.787104 | $0.634151 | $0.618126 | $0.70929 | $0.833748 | $0.71688 | $0.655083 | $0.632343 | $0.370436 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: FMS
2026-06-10 19:39:02
Fresenius Medical Care shares have reached a new 4-week high, trading around EUR 42 in Xetra, signaling a short-term technical turnaround for the dialysis provider. Despite this breakout, the current price is still below its 52-week high of EUR 50.76. The company's fundamental business model focuses on dialysis treatments, with developments like value-based care initiatives at Interwell Health influencing its market position.
2026-06-09 02:39:43
Fresenius Medical Care (FMS) is grappling with increasing kidney disease prevalence and the associated demand for dialysis services, driving a shift towards home dialysis and advanced in-center technologies. The company's large-scale rollout of the 5008X system for high-volume hemodiafiltration (HDF) is central to its strategy, aiming to improve patient outcomes and stabilize service demand amid rising costs and capacity constraints. While 2026 is anticipated to be a year of significant investment and potential operational drag due to this transition, the long-term benefits in clinical quality, efficiency, and market share are expected to materialize more fully in 2027 and beyond.
2026-06-07 09:10:12
Fiduciary Management Inc. WI reduced its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 9.1% in the fourth quarter, selling 495,419 shares. Despite this, other institutions increased their holdings, with institutional investors now owning 8.37% of the company. Analysts have a "Strong Sell" consensus rating for FMS, with an average price target of $28.00, while the company recently increased its annual dividend to $0.8716 per share.
2026-06-07 03:10:12
FMCNA has launched its Kinexus digital health platform across the US to improve home and in-center peritoneal dialysis and hemodialysis care. The platform, which includes Kinexus Therapy Monitor and Kinexus Care Pathways, aims to enhance patient engagement, streamline workflows, and enable data-driven clinical decision-making. Future developments will integrate artificial intelligence and predictive analytics to further personalize care.
2026-06-06 08:31:00
Fresenius Medical Care AG & Co. (FMS) has launched kinexus, a new digital platform designed to support home dialysis programs by integrating remote therapy monitoring, prescription management, and operational workflows for both peritoneal dialysis and home hemodialysis. This move is expected to streamline care, improve patient outcomes, and strengthen FMS's position in the growing home dialysis market, which is projected to reach $6 billion by 2026. Despite a recent Zacks Rank of #5 (Strong Sell) for FMS, the company sees significant growth potential in digital healthcare solutions.
2026-06-05 15:38:44
Fresenius Medical Care AG & Co. (FMS) has launched kinexus, a new digital platform designed to enhance home dialysis programs. This platform integrates remote monitoring, prescription management, and operational workflows for both peritoneal dialysis (PD) and home hemodialysis (HHD). The launch aims to strengthen home dialysis through digital infrastructure, capitalize on the growing home dialysis market, and streamline patient care by consolidating various management aspects into a single system.
